Research peptide blend supplied in Australia by Pulse Biolabs for laboratory use. Available in 10mg, 20mg.
One vial, more than one compound. Each component has its own research note.
BPC-157 and TB-500 (thymosin β4) in one vial. The labelled amount of each component in the 10 mg and 20 mg presentations is being confirmed against the batch report and is not stated here until it is. No controlled study has tested BPC-157 and thymosin β4 together, and none has tested this premixed vial. The one published report of the pair in people is a small, uncontrolled chart review of separate knee injections. Combining compounds in one vial does not add their studies together.
| Presentation | Code | Status | Price |
|---|---|---|---|
| 10mg | BB10 | In stock | $110 |
| 20mg | BB20 | In stock | $150 |
No batch-specific test report is currently published for this product. No report is published for 10mg, 20mg. One document is on file for this product, but which presentation it belongs to is unresolved (its measured amounts do not match the labelled presentation it is filed under) and is being reconciled; it is not counted as a report for any presentation until that is settled. Each report describes the sample and the tests shown on it. A purity result does not by itself establish identity, quantity, sterility or endotoxin status unless those tests appear on the report, and a report for one batch does not describe another.
| Presentation | Report | Batch | |
|---|---|---|---|
| 10mg (association unconfirmed) | manufacturer certificate | no batch reference published (internal label: Original (Undated)) | Open |
All BPC + TB Blend documents →
Supplied as lyophilised (freeze-dried) powder in a single sealed vial containing more than one peptide. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Because the components differ in stability, solvent choice and handling after reconstitution are a matter for the laboratory’s own procedures and are not specified here.
The statuses below are the components’. A finished mixture is subject both to any restriction on its components and to the requirements that apply to it as a product; neither is settled by adding the components’ statuses together.